Electronic Monitoring Of Mom's Schedule (eMOMS™): Protocol for a feasibility randomized controlled trial to improve postpartum weight, blood sugars, and breastfeeding among high BMI women
- PMID: 32346648
- PMCID: PMC7183152
- DOI: 10.1016/j.conctc.2020.100565
Electronic Monitoring Of Mom's Schedule (eMOMS™): Protocol for a feasibility randomized controlled trial to improve postpartum weight, blood sugars, and breastfeeding among high BMI women
Erratum in
-
Erratum regarding missing Declaration of Competing Interest statements in previously published articles.Contemp Clin Trials Commun. 2020 Dec 10;20:100691. doi: 10.1016/j.conctc.2020.100691. eCollection 2020 Dec. Contemp Clin Trials Commun. 2020. PMID: 33392415 Free PMC article.
Abstract
Background: Overweight and obesity are major risk factors for gestational diabetes among U.S. women. Evidence suggests that longer duration of breastfeeding among women with a history of gestational diabetes is associated with lower incidence of developing type 2 diabetes after pregnancy. Women may potentially benefit from a lifestyle change program that includes breastfeeding education and support.
Purpose: To describe the design and justification of a combined breastfeeding, national Diabetes Prevention Program (DPP)-based feasibility randomized controlled trial, the electronic Monitoring Of Mom's Schedule (eMOMSTM) study. eMOMSTM compares the feasibility and efficacy of three interventions on six-month postpartum weight loss among women with a BMI ≥25.
Methods: The intervention is delivered via Facebook and includes three groups: DPP and breastfeeding (eMOMS1); DPP only (eMOMS2); and Usual Care (eMOMS3). Recruitment is ongoing at two clinical sites (rural and urban). A total of 72 women, 24 per group, will be randomly assigned to one of the three groups. It is anticipated that women in eMOMS1 will have greater weight loss and increased length of breastfeeding at three and six months postpartum compared to women in eMOMS2 and eMOMS3. Additional data will be collected on metabolic markers, anthropometrics, physical activity, nutrition, breastfeeding, and depression. Program cost will be compared to that of traditionally scheduled group meetings. Expected study completion date: October 2021.
Conclusions: This study has the potential to define a high impact, cost effective intervention that can improve public health by reducing negative health outcomes associated with gestational diabetes among an at-risk population.
Keywords: Breastfeeding; DPP; Diabetes; Reproductive age women; Social media; Weight loss.
© 2020 The Authors.
Figures
References
-
- Casagrande S.S., Linder B., Cowie C.C. Prevalence of gestational diabetes and subsequent Type 2 diabetes among U.S. women. Diabetes Res. Clin. Pract. 2018;141:200–208. - PubMed
-
- Metzger B.E., Gabbe S.G., Persson B., Buchanan T.A., Catalano P.M., Damm P. The diagnosis of gestational diabetes mellitus: new paradigms or status quo? J. Matern. Fetal Neonatal Med. 2012;25(12):2564–2569. - PubMed
-
- Ovesen P.G., Jensen D.M., Damm P., Rasmussen S., Kesmodel U.S. Maternal and neonatal outcomes in pregnancies complicated by gestational diabetes, a nation-wide study. J. Matern. Fetal Neonatal Med. 2015:1–5. - PubMed
-
- Saydah S.H., Chandra A., Eberhardt M.S. Pregnancy experience among women with and without gestational diabetes in the U.S., 1995 National Survey of Family Growth. Diabetes Care. 2005;28(5):1035–1040. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
